Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Honorati, M. C.
Right arrow Articles by Facchini, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Honorati, M. C.
Right arrow Articles by Facchini, A.
Related Collections
Right arrow Osteoarthritis and Cartilage
Right arrow Spondylarthropathies
Right arrow Rheumatoid Arthritis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2001; 40: 522-527
© 2001 British Society for Rheumatology


Original Papers

High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients

M. C. Honorati1,2,, R. Meliconi3, L. Pulsatelli2, S. Canè1, L. Frizziero4 and A. Facchini1,2

1 Laboratorio Immunologia e Genetica, Istituto Codivilla Putti-IOR,
2 Dipartimento Medicina Interna e Gastroenterologia,
3 Dipartimento Medicina Interna, Cardioangiologia ed Epatologia, Università di Bologna and
4 Ospedale Maggiore, Bologna, Italy

Objective. To evaluate the presence of interleukin-17 (IL-17) and the expression of IL-17 receptor (IL-17R) in joint tissues from subjects with different arthritides.

Methods. Immunohistochemistry was used on frozen synovial and cartilage biopsies to identify cells expressing IL-17 and IL-17R.

Results. IL-17 staining was present only in synovial biopsies of rheumatoid arthritis (RA) (seven out of nine cases). IL-17R was expressed by all synovial biopsies evaluated except for three cases of post-traumatic arthritis (PTA). Vascular endothelial cells mainly expressed IL-17R. The percentage of IL-17R+ vessels was the highest in RA synovium and the lowest in PTA. Chondrocytes from all types of arthritides were negative for IL-17 staining, but expressed IL-17R; the highest percentage of positive chondrocytes was found in seronegative spondylarthritis and the lowest in RA.

Conclusions. IL-17-positive cells are found exclusively in RA. On the other hand, synovial endothelial cells and chondrocytes expressing IL-17R are found in the majority of patients with different types of arthritis. This finding suggests a role for a second ligand for IL-17R, which could be either a different cytokine or a different isoform of IL-17.

KEY WORDS: Interleukin-17 receptor, Synovium, Endothelial cells, Chondrocytes, Arthritis.

Correspondence to: M. C. Honorati, Laboratorio di Immunologia e Genetica, Istituto di Ricerca Codivilla Putti-IOR, Via di Barbiano 1/10, 40136 Bologna, Italy.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
G. Shi, M. Ramaswamy, B. P. Vistica, C. A. Cox, C. Tan, E. F. Wawrousek, R. M. Siegel, and I. Gery
Unlike Th1, Th17 Cells Mediate Sustained Autoimmune Inflammation and Are Highly Resistant to Restimulation-Induced Cell Death
J. Immunol., December 1, 2009; 183(11): 7547 - 7556.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
K. Nistala and L. R. Wedderburn
Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis
Rheumatology, June 1, 2009; 48(6): 602 - 606.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Yamaguchi, K. Fujio, H. Shoda, A. Okamoto, N. H. Tsuno, K. Takahashi, and K. Yamamoto
IL-17B and IL-17C Are Associated with TNF-{alpha} Production and Contribute to the Exacerbation of Inflammatory Arthritis
J. Immunol., November 15, 2007; 179(10): 7128 - 7136.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
A. Linden
A Role for the Cytoplasmic Adaptor Protein Act1 in Mediating IL-17 Signaling
Sci. Signal., August 7, 2007; 2007(398): re4 - re4.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
F. Annunziato, L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Fili, S. Ferri, F. Frosali, et al.
Phenotypic and functional features of human Th17 cells
J. Exp. Med., August 6, 2007; 204(8): 1849 - 1861.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
H.-R. Kim, M.-L. Cho, K.-W. Kim, J.-Y. Juhn, S.-Y. Hwang, C.-H. Yoon, S.-H. Park, S.-H. Lee, and H.-Y. Kim
Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-{kappa}B- and p38 MAPK-dependent signalling pathways
Rheumatology, January 1, 2007; 46(1): 57 - 64.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Linden, M. Laan, and G. P. Anderson
Neutrophils, interleukin-17A and lung disease
Eur. Respir. J., January 1, 2005; 25(1): 159 - 172.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
R L van Bezooijen, L van der Wee-Pals, S E Papapoulos, and C W G M Lowik
Interleukin 17 synergises with tumour necrosis factor {alpha} to induce cartilage destruction in vitro
Ann Rheum Dis, October 1, 2002; 61(10): 870 - 876.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Aggarwal and A. L. Gurney
IL-17: prototype member of an emerging cytokine family
J. Leukoc. Biol., January 1, 2002; 71(1): 1 - 8.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.